Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 301 entries
Sorted by: Best Match Show Resources per page
Learning in the field: Comparison of desktop, immersive virtual reality, and actual field trips for place-based STEM education

STEM education

Zhao J, LaFemina P, Carr J, Sajjadi P.
GSID: OQ7EWaTYepAJ
J Zhao, P LaFemina, J Carr, P Sajjadi… - … IEEE conference on …, 2020 - ieeexplore.ieee.org

… Field trips are a key component of learning in STEM disciplines such as geoscience to develop skills, integrate knowledge, and prepare … However, little research has investigated the implications of VFTs in placebased STEM education, and empirical evidence...

Cite
Zhao, J., LaFemina, P., Carr, J., Sajjadi, P., Wallgrün, J. O., & Klippel, A. (2020, March). Learning in the field: Comparison of desktop, immersive virtual reality, and actual field trips for place-based STEM education. In 2020 IEEE conference on virtual reality and 3D user interfaces (VR) (pp. 893-902). IEEE.
Zhao, Jiayan, et al. "Learning in the field: Comparison of desktop, immersive virtual reality, and actual field trips for place-based STEM education." 2020 IEEE conference on virtual reality and 3D user interfaces (VR). IEEE, 2020.
Copy Download .nbib Format: MLA
Prescription Extraction from Clinical Notes: Towards Automating EMR Medication Reconciliation.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science

Wang Y, Steinhubl SR, Defilippi C, Ng K, Ebadollahi S, Stewart WF, Byrd RJ.
PMID: 26306266
AMIA Jt Summits Transl Sci Proc. 2015 Mar 25;2015:188-93. eCollection 2015.

Medication in for ma lion is one of [he most important clinical data types in electronic medical records (EMR) This study developed an NLP application (PredMED) to extract full prescriptions and their relevant components from a large corpus of...

Cite
Wang Y, Steinhubl SR, Defilippi C, et al. Prescription Extraction from Clinical Notes: Towards Automating EMR Medication Reconciliation. AMIA Jt Summits Transl Sci Proc. 2015;2015:188-93
Wang, Y., Steinhubl, S. R., Defilippi, C., Ng, K., Ebadollahi, S., Stewart, W. F., & Byrd, R. J. (2015). Prescription Extraction from Clinical Notes: Towards Automating EMR Medication Reconciliation. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2015188-93.
Wang, Yajuan, et al. "Prescription Extraction from Clinical Notes: Towards Automating EMR Medication Reconciliation." AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science vol. 2015 (2015): 188-93.
Wang Y, Steinhubl SR, Defilippi C, Ng K, Ebadollahi S, Stewart WF, Byrd RJ. Prescription Extraction from Clinical Notes: Towards Automating EMR Medication Reconciliation. AMIA Jt Summits Transl Sci Proc. 2015 Mar 25;2015:188-93. eCollection 2015. PMID: 26306266; PMCID: PMC4525262.
Copy Download .nbib Format: NLM
Next-Generation Diagnostics for Genodermatoses.

The Journal of investigative dermatology

Cho RJ, Simpson MA, McGrath JA.
PMID: 26875439
J Invest Dermatol. 2012 Nov;132:E27-8. doi: 10.1038/skinbio.2012.8.

No abstract available.

Cite
Cho RJ, Simpson MA, McGrath JA. Next-Generation Diagnostics for Genodermatoses. J Invest Dermatol. 2012;132:E27-8doi: 10.1038/skinbio.2012.8.
Cho, R. J., Simpson, M. A., & McGrath, J. A. (2012). Next-Generation Diagnostics for Genodermatoses. The Journal of investigative dermatology, 132E27-8. https://doi.org/10.1038/skinbio.2012.8
Cho, Raymond J, et al. "Next-Generation Diagnostics for Genodermatoses." The Journal of investigative dermatology vol. 132 (2012): E27-8. doi: https://doi.org/10.1038/skinbio.2012.8
Cho RJ, Simpson MA, McGrath JA. Next-Generation Diagnostics for Genodermatoses. J Invest Dermatol. 2012 Nov;132:E27-8. doi: 10.1038/skinbio.2012.8. PMID: 26875439.
Copy Download .nbib Format: NLM
Subversion of Autophagy by Kaposi's Sarcoma-Associated Herpesvirus Impairs Oncogene-Induced Senescence.

Cell host & microbe

Leidal AM, Cyr DP, Hill RJ, Lee PW, McCormick C.
PMID: 27281574
Cell Host Microbe. 2016 Jun 08;19(6):901. doi: 10.1016/j.chom.2016.05.006.

No abstract available.

Cite
Leidal AM, Cyr DP, Hill RJ, et al. Subversion of Autophagy by Kaposi's Sarcoma-Associated Herpesvirus Impairs Oncogene-Induced Senescence. Cell Host Microbe. 2016;19(6):901doi: 10.1016/j.chom.2016.05.006.
Leidal, A. M., Cyr, D. P., Hill, R. J., Lee, P. W., & McCormick, C. (2016). Subversion of Autophagy by Kaposi's Sarcoma-Associated Herpesvirus Impairs Oncogene-Induced Senescence. Cell host & microbe, 19(6), 901. https://doi.org/10.1016/j.chom.2016.05.006
Leidal, Andrew M, et al. "Subversion of Autophagy by Kaposi's Sarcoma-Associated Herpesvirus Impairs Oncogene-Induced Senescence." Cell host & microbe vol. 19,6 (2016): 901. doi: https://doi.org/10.1016/j.chom.2016.05.006
Leidal AM, Cyr DP, Hill RJ, Lee PW, McCormick C. Subversion of Autophagy by Kaposi's Sarcoma-Associated Herpesvirus Impairs Oncogene-Induced Senescence. Cell Host Microbe. 2016 Jun 08;19(6):901. doi: 10.1016/j.chom.2016.05.006. PMID: 27281574.
Copy Download .nbib Format: NLM
Heterologous expression of the avirulence gene .

Chemical science

Song Z, Bakeer W, Marshall JW, Yakasai AA, Khalid RM, Collemare J, Skellam E, Tharreau D, Lebrun MH, Lazarus CM, Bailey AM, Simpson TJ, Cox RJ.
PMID: 29142718
Chem Sci. 2015 Aug 01;6(8):4837-4845. doi: 10.1039/c4sc03707c. Epub 2015 Jun 01.

The

Cite
Song Z, Bakeer W, Marshall JW, et al. Heterologous expression of the avirulence gene . Chem Sci. 2015;6(8):4837-4845doi: 10.1039/c4sc03707c.
Song, Z., Bakeer, W., Marshall, J. W., Yakasai, A. A., Khalid, R. M., Collemare, J., Skellam, E., Tharreau, D., Lebrun, M. H., Lazarus, C. M., Bailey, A. M., Simpson, T. J., & Cox, R. J. (2015). Heterologous expression of the avirulence gene . Chemical science, 6(8), 4837-4845. https://doi.org/10.1039/c4sc03707c
Song, Zhongshu, et al. "Heterologous expression of the avirulence gene ." Chemical science vol. 6,8 (2015): 4837-4845. doi: https://doi.org/10.1039/c4sc03707c
Song Z, Bakeer W, Marshall JW, Yakasai AA, Khalid RM, Collemare J, Skellam E, Tharreau D, Lebrun MH, Lazarus CM, Bailey AM, Simpson TJ, Cox RJ. Heterologous expression of the avirulence gene . Chem Sci. 2015 Aug 01;6(8):4837-4845. doi: 10.1039/c4sc03707c. Epub 2015 Jun 01. PMID: 29142718; PMCID: PMC5667575.
Copy Download .nbib Format: NLM
Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis.

Case reports in cardiology

Daruwalla VJ, Parekh K, Tahir H, Collins JD, Carr J.
PMID: 26106490
Case Rep Cardiol. 2015;2015:921247. doi: 10.1155/2015/921247. Epub 2015 May 27.

Raghib Syndrome is a rare developmental complex, which consists of persistence of the left superior vena cava (PLSVC) along with coronary sinus ostial atresia and atrial septal defect. This Raghib complex anomaly has also been associated with other congenital...

Cite
Daruwalla VJ, Parekh K, Tahir H, et al. Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis. Case Rep Cardiol. 2015;2015:921247doi: 10.1155/2015/921247.
Daruwalla, V. J., Parekh, K., Tahir, H., Collins, J. D., & Carr, J. (2015). Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis. Case reports in cardiology, 2015921247. https://doi.org/10.1155/2015/921247
Daruwalla, Vistasp J, et al. "Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis." Case reports in cardiology vol. 2015 (2015): 921247. doi: https://doi.org/10.1155/2015/921247
Daruwalla VJ, Parekh K, Tahir H, Collins JD, Carr J. Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis. Case Rep Cardiol. 2015;2015:921247. doi: 10.1155/2015/921247. Epub 2015 May 27. PMID: 26106490; PMCID: PMC4461698.
Copy Download .nbib Format: NLM
How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke.

Journal of cardiovascular echography

Falanga G, Carerj S, Oreto G, Khandheria B, Zito C.
PMID: 28465931
J Cardiovasc Echogr. 2015 Apr-Jun;25(2):46-53. doi: 10.4103/2211-4122.161779.

In the first part of this review, we reminded that patent foramen ovale (PFO) is a slit or tunnel-like passage in the interatrial septum occurring in approximately 25% of the population and that a number of conditions have been...

Cite
Falanga G, Carerj S, Oreto G, et al. How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke. J Cardiovasc Echogr. 2015;25(2):46-53doi: 10.4103/2211-4122.161779.
Falanga, G., Carerj, S., Oreto, G., Khandheria, B., & Zito, C. (2015). How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke. Journal of cardiovascular echography, 25(2), 46-53. https://doi.org/10.4103/2211-4122.161779
Falanga, Gabriella, et al. "How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke." Journal of cardiovascular echography vol. 25,2 (2015): 46-53. doi: https://doi.org/10.4103/2211-4122.161779
Falanga G, Carerj S, Oreto G, Khandheria B, Zito C. How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke. J Cardiovasc Echogr. 2015 Apr-Jun;25(2):46-53. doi: 10.4103/2211-4122.161779. PMID: 28465931; PMCID: PMC5353430.
Copy Download .nbib Format: NLM
Randomized trial evaluating intraoperative ultrasound guidance for palpable breast cancer excision.

Expert review of medical devices

Bunting PW, Cyr AE, Margenthaler JA.
PMID: 23668704
Expert Rev Med Devices. 2013 May;10(3):317-20. doi: 10.1586/erd.13.11.

Breast-conserving surgery with lumpectomy and adjuvant radiation is the treatment of choice for the majority of early-stage breast cancers. The goals of surgery are to remove the tumor with adequate margins while maintaining an excellent cosmetic outcome. Multiple factors...

Cite
Bunting PW, Cyr AE, Margenthaler JA. Randomized trial evaluating intraoperative ultrasound guidance for palpable breast cancer excision. Expert Rev Med Devices. 2013;10(3):317-20doi: 10.1586/erd.13.11.
Bunting, P. W., Cyr, A. E., & Margenthaler, J. A. (2013). Randomized trial evaluating intraoperative ultrasound guidance for palpable breast cancer excision. Expert review of medical devices, 10(3), 317-20. https://doi.org/10.1586/erd.13.11
Bunting, Pamela W, et al. "Randomized trial evaluating intraoperative ultrasound guidance for palpable breast cancer excision." Expert review of medical devices vol. 10,3 (2013): 317-20. doi: https://doi.org/10.1586/erd.13.11
Bunting PW, Cyr AE, Margenthaler JA. Randomized trial evaluating intraoperative ultrasound guidance for palpable breast cancer excision. Expert Rev Med Devices. 2013 May;10(3):317-20. doi: 10.1586/erd.13.11. PMID: 23668704.
Copy Download .nbib Format: NLM
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.

Frontiers in oncology

Repka MC, Guleria S, Cyr RA, Yung TM, Koneru H, Chen LN, Lei S, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch J, Collins SP.
PMID: 27242962
Front Oncol. 2016 May 18;6:122. doi: 10.3389/fonc.2016.00122. eCollection 2016.

BACKGROUND: Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to the adjacent critical organs. Large fraction sizes may increase urinary morbidity due to unavoidable treatment of the prostatic urethra. This study...

Cite
Repka MC, Guleria S, Cyr RA, et al. Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Front Oncol. 2016;6:122doi: 10.3389/fonc.2016.00122.
Repka, M. C., Guleria, S., Cyr, R. A., Yung, T. M., Koneru, H., Chen, L. N., Lei, S., Collins, B. T., Krishnan, P., Suy, S., Dritschilo, A., Lynch, J., & Collins, S. P. (2016). Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Frontiers in oncology, 6122. https://doi.org/10.3389/fonc.2016.00122
Repka, Michael C, et al. "Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction." Frontiers in oncology vol. 6 (2016): 122. doi: https://doi.org/10.3389/fonc.2016.00122
Repka MC, Guleria S, Cyr RA, Yung TM, Koneru H, Chen LN, Lei S, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch J, Collins SP. Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Front Oncol. 2016 May 18;6:122. doi: 10.3389/fonc.2016.00122. eCollection 2016. PMID: 27242962; PMCID: PMC4870496.
Copy Download .nbib Format: NLM
Evidence for Opposing Effects of Calmodulin on Cortical Microtubules.

Plant physiology

Fisher DD, Gilroy S, Cyr RJ.
PMID: 12226434
Plant Physiol. 1996 Nov;112(3):1079-1087. doi: 10.1104/pp.112.3.1079.

Microtubule integrity within the cortical array was visualized in detergent-lysed carrot (Daucus carota L.) protoplasts that were exposed to various exogenous levels of Ca2+ and calmodulin (CaM). CaM appears to help stabilize cortical microtubules against the destabilizing action of...

Cite
Fisher DD, Gilroy S, Cyr RJ. Evidence for Opposing Effects of Calmodulin on Cortical Microtubules. Plant Physiol. 1996;112(3):1079-1087doi: 10.1104/pp.112.3.1079.
Fisher, D. D., Gilroy, S., & Cyr, R. J. (1996). Evidence for Opposing Effects of Calmodulin on Cortical Microtubules. Plant physiology, 112(3), 1079-1087. https://doi.org/10.1104/pp.112.3.1079
Fisher, D. D., et al. "Evidence for Opposing Effects of Calmodulin on Cortical Microtubules." Plant physiology vol. 112,3 (1996): 1079-1087. doi: https://doi.org/10.1104/pp.112.3.1079
Fisher DD, Gilroy S, Cyr RJ. Evidence for Opposing Effects of Calmodulin on Cortical Microtubules. Plant Physiol. 1996 Nov;112(3):1079-1087. doi: 10.1104/pp.112.3.1079. PMID: 12226434; PMCID: PMC158034.
Copy Download .nbib Format: NLM
Ultrastructure of mixed plant virus infection: bean yellow mosaic virus with cowpea severe mosaic virus or cowpea mosaic virus in bean.

Virology

Carr RJ, Kim KS.
PMID: 18638866
Virology. 1983 Jan 30;124(2):338-48. doi: 10.1016/0042-6822(83)90350-1.

Ultrastructural responses of bean leaf cells simultaneously infected with two morphologically distinct RNA viruses, cowpea mosaic virus (CPMV) and bean yellow mosaic virus (BYMV), or cowpea severe mosaic virus (CSMV) and BYMV, were studied in situ. The major effects...

Cite
Carr RJ, Kim KS. Ultrastructure of mixed plant virus infection: bean yellow mosaic virus with cowpea severe mosaic virus or cowpea mosaic virus in bean. Virology. 1983;124(2):338-48doi: 10.1016/0042-6822(83)90350-1.
Carr, R. J., & Kim, K. S. (1983). Ultrastructure of mixed plant virus infection: bean yellow mosaic virus with cowpea severe mosaic virus or cowpea mosaic virus in bean. Virology, 124(2), 338-48. https://doi.org/10.1016/0042-6822(83)90350-1
Carr, R J, and Kim, K S. "Ultrastructure of mixed plant virus infection: bean yellow mosaic virus with cowpea severe mosaic virus or cowpea mosaic virus in bean." Virology vol. 124,2 (1983): 338-48. doi: https://doi.org/10.1016/0042-6822(83)90350-1
Carr RJ, Kim KS. Ultrastructure of mixed plant virus infection: bean yellow mosaic virus with cowpea severe mosaic virus or cowpea mosaic virus in bean. Virology. 1983 Jan 30;124(2):338-48. doi: 10.1016/0042-6822(83)90350-1. PMID: 18638866.
Copy Download .nbib Format: NLM
Status of the electron cyclotron resonance charge breeder for the (252)Cf fission source project at ATLAS.

The Review of scientific instruments

Vondrasek RC, Scott R, Carr J, Pardo RC.
PMID: 18315156
Rev Sci Instrum. 2008 Feb;79(2):02A901. doi: 10.1063/1.2802580.

The construction of the Californium Rare Ion Breeder Upgrade, a new radioactive beam facility for the Argonne tandem linac accelerator system (ATLAS), is in progress. The facility will use fission fragments from a 1 Ci (252)Cf source, thermalized and...

Cite
Vondrasek RC, Scott R, Carr J, et al. Status of the electron cyclotron resonance charge breeder for the (252)Cf fission source project at ATLAS. Rev Sci Instrum. 2008;79(2):02A901doi: 10.1063/1.2802580.
Vondrasek, R. C., Scott, R., Carr, J., & Pardo, R. C. (2008). Status of the electron cyclotron resonance charge breeder for the (252)Cf fission source project at ATLAS. The Review of scientific instruments, 79(2), 02A901. https://doi.org/10.1063/1.2802580
Vondrasek, R C, et al. "Status of the electron cyclotron resonance charge breeder for the (252)Cf fission source project at ATLAS." The Review of scientific instruments vol. 79,2 (2008): 02A901. doi: https://doi.org/10.1063/1.2802580
Vondrasek RC, Scott R, Carr J, Pardo RC. Status of the electron cyclotron resonance charge breeder for the (252)Cf fission source project at ATLAS. Rev Sci Instrum. 2008 Feb;79(2):02A901. doi: 10.1063/1.2802580. PMID: 18315156.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 301 entries